arrow
L

Ly-Mee Yu

University of Oxford
H指数:71
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Automated virtual reality therapy to treat needle fears (trypanophobia) in adolescents in England: a proof-of-concept cohort study and a Phase II randomised controlled trial

自动化虚拟现实疗法治疗英格兰青少年针头恐惧(血管恐惧症):一项概念验证队列研究及II期随机对照试验

2026-07-150
OAAI
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK

普拉克索(Pramipexole)用于难治性单相抑郁症急性期的加量治疗:一项在英国进行的安慰剂对照、双盲、随机试验

2025-06-290
OAAI
A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration

一种病毒免疫学模型,用于表征莫纳皮拉韦在感染SARS-CoV-2的门急诊患者中的抗病毒作用:对治疗持续时间的启示

2025-04-010
PRE
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
2024-10-010
OAAI
Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial
2024-09-300
OAAI
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

伊维菌素用于社区成人新型冠状病毒肺炎 (原则): 一项开放、随机、对照、适应性的短期和长期结果平台试验

2024-04-015
OAAI
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial
2024-03-014
OAAI
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

molnupiravir在高危成人门诊患者中SARS-CoV-2病毒和抗体反应的随机对照试验

2024-02-2310
OAAI
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial

莫那比拉韦对高危社区新型冠状病毒肺炎成人的成本效用分析: 全景试验的经济评估

2024-01-162
OAAI
Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses
2023-11-018
OAAI
Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT) a pragmatic, superiority, open-label, randomised controlled trial
LANCET
IF88.5
2023-09-0116
OAAI
A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England (SleepWell): a parallel group, single-blind, randomised controlled feasibility trial

针对英格兰精神病超高风险年轻人的睡眠问题的针对性心理治疗 (SleepWell): 一项平行组,单盲,随机对照可行性试验

2023-09-019
OAAI